Blood Glucose Monitoring Devices Industry Overview
The global blood glucose monitoring devices market size was valued at 11.71 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.0% from 2022 to 2030. The key drivers of the market are the rising incidence of diabetes and the increasing geriatric population prone to diabetes. The market growth is further propelled by the increasing awareness regarding diabetes preventive care and new product launches. Diabetes is a serious and growing problem globally, where the inefficiency of the pancreas to produce insulin results in an increase in blood glucose levels. According to the International Diabetes Federation, in 2021, around 537 million people were diagnosed with diabetes, this number is expected to increase to 643 million by 2030 and 783 million by 2045.
Blood glucose monitoring (BGM) devices are helpful for patients with diabetes in four ways. These devices enable patients and clinicians to detect high or low blood glucose levels, allowing for therapy modifications and protecting patients by confirming acute hypoglycemia or hyperglycemia promptly and by offering patients greater self-care. The technology facilitates patient education about diabetes and its management and encourages people to adopt healthier habits. Blood glucose devices are available in a multitude of sizes, prices, testing times, and ease of use.
Gather more insights about the market drivers, restraints, and growth of the Global Blood Glucose Monitoring Devices market
The COVID-19 pandemic has opened new opportunities for blood glucose monitoring devices and these devices gained more popularity in the diabetic care market. Awareness regarding the benefits of blood glucose monitoring devices increased among the consumers as during the pandemic, there had been an emphasis on the use of virtual clinics and telemedicine for diabetic management. The blood glucose monitoring devices helped patients and healthcare providers improve glycemic control and potentially increase patient self-management, thus changing diabetes care significantly. Further, a surge in the demand for blood glucose monitoring devices due to the quick response by major market players during the Covid-19 pandemic.
The rapidly changing lifestyle such as the consumption of alcohol and smoking is contributing to the rise in the number of diabetes patients, worldwide. Obesity is also one of the major factors contributing to diabetes. Furthermore, the increasing geriatric population is propelling market growth. According to the WHO, by 2050, the world’s aging population will be about 2 billion from 1 billion in 2020.
Browse through Grand View Research's Medical Devices Industry Research Reports.
eHealth Devices Market - The global eHealth devices market size was valued at USD 15.0 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 9.4% from 2022 to 2028.
Insulin Delivery Devices Market - The global insulin delivery devices market size was valued at USD 12.5 billion in 2021 and is anticipated to expand at a compound annual growth rate (CAGR) of 7.4% from 2022 to 2030.
Blood Glucose Monitoring Devices Market Segmentation
Grand View Research has segmented the global blood glucose monitoring devices market based on product, end-use, and region:
Blood Glucose Monitoring Devices Product Outlook (Revenue, USD Million, 2017 - 2030)
- Self-monitoring Devices
- Continuous Blood Glucose Monitoring Devices
Blood Glucose Monitoring Devices End-use Outlook (Revenue, USD Million, 2017 - 2030)
- Hospitals
- Home Care
- Diagnostic Centers
Blood Glucose Monitoring Devices Regional Outlook (Revenue, USD Million, 2017 - 2030)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Market Share Insights
May 2021: Roche collaborated with Eli Lilly and Company, to work towards enhancing the management of insulin pen therapy. With this collaboration, Roche follows its ambition to create an open ecosystem including its own and partner devices, solutions, and services, across the continuum of care in diabetes.
Key Companies profiled:
Some prominent players in the global blood glucose monitoring devices market include:
- Abbott Laboratories
- Medtronic plc
- F. Hoffmann-La Roche Ltd.
- Ascensia Diabetes Care
- Dexcom, Inc.
- Sanofi
- Novo Nordisk
- Insulet Corporation
- Ypsomed Holdings
- GlySens Incorporated
Order a free sample PDF of the Blood Glucose Monitoring Devices Market Intelligence Study, published by Grand View Research.
No comments:
Post a Comment